---
layout: post
title: "35 家仿制药制造商与 MPP 签署协议生产辉瑞抗病毒复制药物"
date: 2022-03-18T01:51:59.000Z
author: Solidot
from: https://www.solidot.org/story?sid=70982
tags: [ Solidot ]
comments: True
categories: [ Solidot ]
---
<!--1647568319000-->
[35 家仿制药制造商与 MPP 签署协议生产辉瑞抗病毒复制药物](https://www.solidot.org/story?sid=70982)
------

<div>
匿名读者 写道<i> "<a href="https://medicinespatentpool.org/news-publications-post/35-generic-manufacturers-sign-agreements-with-mpp-to-produce-low-cost-generic-versions-of-pfizers-oral-covid-19-treatment-nirmatrelvir-in-combination-with-ritonavir-for-supply-in-95-low-and" target="_blank">药品专利池</a>（Medicines Patent Pool，MPP）宣布与 35 家公司签署协议生产辉瑞 COVID-19 口服治疗药物<a href="https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html" target="_blank">奈玛特韦片</a>（nirmatrelvir）。</i><p><i>根据药品专利池与辉瑞达成的自愿许可协议，只要新冠疫情仍被世界卫生组织列为国际关注的突发公共卫生事件，就将<a href="https://www.solidot.org/story?sid=69645" target="_blank">免除</a>协议涵盖的所有国家药物销售的特许权使用费。 "</i></p>
</div>
